Corient Capital Partners’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $786K | Buy |
5,500
+118
| +2% | +$16.9K | 0.06% | 253 |
|
|
2022
Q2 | $769K | Buy |
5,382
+763
| +17% | +$109K | 0.06% | 263 |
|
|
2022
Q1 | $796K | Buy |
4,619
+367
| +9% | +$63.2K | 0.05% | 287 |
|
|
2021
Q4 | $1.08M | Buy |
4,252
+270
| +7% | +$68.5K | 0.07% | 219 |
|
|
2021
Q3 | $1.53M | Buy |
3,982
+544
| +16% | +$209K | 0.11% | 170 |
|
|
2021
Q2 | $808K | Buy |
3,438
+521
| +18% | +$122K | 0.06% | 251 |
|
|
2021
Q1 | $382K | Buy |
2,917
+298
| +11% | +$39K | 0.03% | 380 |
|
|
2020
Q4 | $274K | Buy |
+2,619
| New | +$274K | 0.03% | 407 |
|